Proactiveinvestors Australia HemoGenyx Pharmaceuticals https://www.proactiveinvestors.com.au Proactiveinvestors Australia HemoGenyx Pharmaceuticals RSS feed en Fri, 18 Oct 2019 07:29:45 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Hemogenyx Pharmaceuticals making pleasing progress https://www.proactiveinvestors.com.au/companies/news/903786/hemogenyx-pharmaceuticals-making-pleasing-progress-903786.html Mon, 30 Sep 2019 13:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903786/hemogenyx-pharmaceuticals-making-pleasing-progress-903786.html Hemogenyx Pharmaceuticals PLC advisory board member recognised for breast cancer breakthrough https://www.proactiveinvestors.com.au/companies/news/902550/hemogenyx-pharmaceuticals-plc-advisory-board-member-recognised-for-breast-cancer-breakthrough-902550.html Thu, 12 Sep 2019 06:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/902550/hemogenyx-pharmaceuticals-plc-advisory-board-member-recognised-for-breast-cancer-breakthrough-902550.html Hemogenyx files new patent application for CDX technology https://www.proactiveinvestors.com.au/companies/news/223792/hemogenyx-files-new-patent-application-for-cdx-technology-223792.html Fri, 12 Jul 2019 06:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223792/hemogenyx-files-new-patent-application-for-cdx-technology-223792.html Hemogenyx develops new mouse model which could play a big role in future wars https://www.proactiveinvestors.com.au/companies/news/222659/hemogenyx-develops-new-mouse-model-which-could-play-a-big-role-in-future-wars-222659.html Mon, 24 Jun 2019 07:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222659/hemogenyx-develops-new-mouse-model-which-could-play-a-big-role-in-future-wars-222659.html Hemogenyx reports encouraging data for bone marrow transplant therapy https://www.proactiveinvestors.com.au/companies/news/221951/hemogenyx-reports-encouraging-data-for-bone-marrow-transplant-therapy-221951.html Wed, 12 Jun 2019 12:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221951/hemogenyx-reports-encouraging-data-for-bone-marrow-transplant-therapy-221951.html Hemogenyx soars as CDX antibody demonstrates effectiveness against acute myeloid leukemia https://www.proactiveinvestors.com.au/companies/news/221538/hemogenyx-soars-as-cdx-antibody-demonstrates-effectiveness-against-acute-myeloid-leukemia-221538.html Wed, 05 Jun 2019 07:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221538/hemogenyx-soars-as-cdx-antibody-demonstrates-effectiveness-against-acute-myeloid-leukemia-221538.html Hemogenyx Pharmaceuticals delivers encouraging data on antibody drug candidate https://www.proactiveinvestors.com.au/companies/news/221198/hemogenyx-pharmaceuticals-delivers-encouraging-data-on-antibody-drug-candidate-221198.html Thu, 30 May 2019 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221198/hemogenyx-pharmaceuticals-delivers-encouraging-data-on-antibody-drug-candidate-221198.html Hemogenyx says progress continuing towards Investigational New Drug submission for CDX antibody https://www.proactiveinvestors.com.au/companies/news/219288/hemogenyx-says-progress-continuing--towards-investigational-new-drug-submission-for-cdx-antibody-219288.html Mon, 29 Apr 2019 14:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219288/hemogenyx-says-progress-continuing--towards-investigational-new-drug-submission-for-cdx-antibody-219288.html Hemogenyx Pharmaceuticals chief to present at immunotherapy conference https://www.proactiveinvestors.com.au/companies/news/213583/hemogenyx-pharmaceuticals-chief-to-present-at-immunotherapy-conference-213583.html Wed, 30 Jan 2019 15:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213583/hemogenyx-pharmaceuticals-chief-to-present-at-immunotherapy-conference-213583.html Hemogenyx Pharma resetting the bar in blood cancers https://www.proactiveinvestors.com.au/companies/news/213430/hemogenyx-pharma-resetting-the-bar-in-blood-cancers-213430.html Mon, 28 Jan 2019 14:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213430/hemogenyx-pharma-resetting-the-bar-in-blood-cancers-213430.html Hemogenyx set for talks over potential licensing deal with global pharma later this month https://www.proactiveinvestors.com.au/companies/news/212027/hemogenyx-set-for-talks-over-potential-licensing-deal-with-global-pharma-later-this-month-212027.html Mon, 07 Jan 2019 14:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212027/hemogenyx-set-for-talks-over-potential-licensing-deal-with-global-pharma-later-this-month-212027.html Hemogenyx Pharmaceuticals unveils new senior appointment https://www.proactiveinvestors.com.au/companies/news/208479/hemogenyx-pharmaceuticals-unveils-new-senior-appointment-208479.html Mon, 05 Nov 2018 07:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/208479/hemogenyx-pharmaceuticals-unveils-new-senior-appointment-208479.html Orgenesis to invest at least another US$1mln into Hemogenyx as part of latest collaboration deal https://www.proactiveinvestors.com.au/companies/news/207524/orgenesis-to-invest-at-least-another-us1mln-into-hemogenyx-as-part-of-latest-collaboration-deal-207524.html Mon, 22 Oct 2018 13:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207524/orgenesis-to-invest-at-least-another-us1mln-into-hemogenyx-as-part-of-latest-collaboration-deal-207524.html Hemogenyx to receive US$1mln investment from Orgenesis as part of new collaboration deal https://www.proactiveinvestors.com.au/companies/news/207442/hemogenyx-to-receive-us1mln-investment-from-orgenesis-as-part-of-new-collaboration-deal-207442.html Fri, 19 Oct 2018 10:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207442/hemogenyx-to-receive-us1mln-investment-from-orgenesis-as-part-of-new-collaboration-deal-207442.html Hemogenyx teams up with Johnson & Johnson to develop new lupus treatment https://www.proactiveinvestors.com.au/companies/news/207043/hemogenyx-teams-up-with-johnson-johnson-to-develop-new-lupus-treatment-207043.html Mon, 15 Oct 2018 06:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207043/hemogenyx-teams-up-with-johnson-johnson-to-develop-new-lupus-treatment-207043.html HemoGenyx optimistic on CDX antibodies prospects https://www.proactiveinvestors.com.au/companies/news/205996/hemogenyx-optimistic-on-cdx-antibodies-prospects-205996.html Fri, 28 Sep 2018 12:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/205996/hemogenyx-optimistic-on-cdx-antibodies-prospects-205996.html HemoGenyx CEO 'overwhelmed' by speed of progress at the company https://www.proactiveinvestors.com.au/companies/news/309703/hemogenyx-ceo-overwhelmed-by-speed-of-progress-at-the-company-9703.html Tue, 26 Jun 2018 15:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309703/hemogenyx-ceo-overwhelmed-by-speed-of-progress-at-the-company-9703.html Hemogenyx Pharmaceuticals chief hails a year of significant progress https://www.proactiveinvestors.com.au/companies/news/196110/hemogenyx-pharmaceuticals-chief-hails-a-year-of-significant-progress-196110.html Wed, 30 May 2018 15:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196110/hemogenyx-pharmaceuticals-chief-hails-a-year-of-significant-progress-196110.html Hemogenyx teams up with global pharma company to help further develop CDX antibodies https://www.proactiveinvestors.com.au/companies/news/196893/hemogenyx-teams-up-with-global-pharma-company-to-help-further-develop-cdx-antibodies-196893.html Mon, 14 May 2018 07:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196893/hemogenyx-teams-up-with-global-pharma-company-to-help-further-develop-cdx-antibodies-196893.html HemoGenyx CEO says progress 'definitely surpassing expectations' https://www.proactiveinvestors.com.au/companies/news/309270/hemogenyx-ceo-says-progress-definitely-surpassing-expectations--9270.html Fri, 11 May 2018 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309270/hemogenyx-ceo-says-progress-definitely-surpassing-expectations--9270.html HemoGenyx signs collaboration agreement with Rockefeller University to develop new Lupus treatments https://www.proactiveinvestors.com.au/companies/news/196521/hemogenyx-signs-collaboration-agreement-with-rockefeller-university-to-develop-new-lupus-treatments-196521.html Tue, 08 May 2018 06:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196521/hemogenyx-signs-collaboration-agreement-with-rockefeller-university-to-develop-new-lupus-treatments-196521.html Hemogenyx appoints Marc Feldmann, pioneer of anti-TNF therapy for rheumatoid arthritis, as its new executive chairman https://www.proactiveinvestors.com.au/companies/news/194125/hemogenyx-appoints-marc-feldmann-pioneer-of-anti-tnf-therapy-for-rheumatoid-arthritis-as-its-new-executive-chairman-194125.html Tue, 03 Apr 2018 07:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194125/hemogenyx-appoints-marc-feldmann-pioneer-of-anti-tnf-therapy-for-rheumatoid-arthritis-as-its-new-executive-chairman-194125.html Hemogenyx shares leap as it signs collaboration deal with major US biotechnology company https://www.proactiveinvestors.com.au/companies/news/193045/hemogenyx-shares-leap-as-it-signs-collaboration-deal-with-major-us-biotechnology-company-193045.html Tue, 13 Mar 2018 08:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/193045/hemogenyx-shares-leap-as-it-signs-collaboration-deal-with-major-us-biotechnology-company-193045.html HemoGenyx shares soar after news of first solid data on leukemia treatment https://www.proactiveinvestors.com.au/companies/news/192202/hemogenyx-shares-soar-after-news-of-first-solid-data-on-leukemia-treatment-192202.html Mon, 26 Feb 2018 15:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/192202/hemogenyx-shares-soar-after-news-of-first-solid-data-on-leukemia-treatment-192202.html Major Honour for HemoGenyx https://www.proactiveinvestors.com.au/companies/news/308605/major-honour-for-hemogenyx-8605.html Thu, 11 Jan 2018 16:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308605/major-honour-for-hemogenyx-8605.html Hemogenyx happy with progress and recent collaborations https://www.proactiveinvestors.com.au/companies/news/188426/hemogenyx-happy-with-progress-and-recent-collaborations-188426.html Thu, 07 Dec 2017 08:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188426/hemogenyx-happy-with-progress-and-recent-collaborations-188426.html Hemogenyx aims for revolution in blood cancer treatment https://www.proactiveinvestors.com.au/companies/news/185494/hemogenyx-aims-for-revolution-in-blood-cancer-treatment-185494.html Thu, 12 Oct 2017 08:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185494/hemogenyx-aims-for-revolution-in-blood-cancer-treatment-185494.html Hemogenyx Pharmaceuticals to revolutionise bone marrow transplants https://www.proactiveinvestors.com.au/companies/news/308208/hemogenyx-pharmaceuticals-to-revolutionise-bone-marrow-transplants-8208.html Mon, 09 Oct 2017 09:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308208/hemogenyx-pharmaceuticals-to-revolutionise-bone-marrow-transplants-8208.html